GALD vs SDZ: Side-by-Side Comparison
Compare Galderma Group N (GALD) and Sandoz Group AG (SDZ) side by side: market cap CHF 43.03B vs CHF 31.28B, P/E 88.2 vs 42.8. Financials, growth and model signals on Bullrun.
| Metric | GALD | SDZ |
|---|---|---|
| Company | Galderma Group N | Sandoz Group AG |
| Country / Exchange | Switzerland · SW | Switzerland · SW |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic | Drug Manufacturers - Specialty & Generic |
| Market cap | CHF 43.03B | CHF 31.28B |
| P/E ratio | 88.2 | 42.8 |
| Dividend yield | 0.19% | 1.11% |
| Valuation model | — | — |
| Revenue (FY2025) | CHF 5.24B | CHF 11.16B |
| Revenue growth YoY | +18.0% | +7.4% |
| Net income | CHF 613.00M | CHF 914.00M |
| Gross margin | 68.9% | 47.4% |
| Diluted EPS | — | 2.09 |